National Lung Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Frias, Melchor V
COMET-PACE, NCT05124210 / 2021-003717-18: Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Terminated
2
8
US
Sotrovimab
GlaxoSmithKline, Vir Biotechnology, Inc.
COVID-19
06/23
06/23
DRAMATIC, NCT03828201: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Recruiting
2
220
RoW
Delamanid, Deltyba, Levofloxacin, Levaquin, Bedaquiline, Sirturo, Clofazimine, Lamprene, Linezolid, Zyvox
Boston University, Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines
Tuberculosis, Multidrug-Resistant
05/27
05/27
NCT05477186: Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Completed
1
185
US, RoW
CV0501 (3 μg), CV0501 (6 μg), CV0501 (12 μg), CV0501 (25 μg), CV0501 (50 μg), CV0501 (100 μg), CV0501 (200 μg)
GlaxoSmithKline
COVID-19, SARS-CoV-2
08/23
08/23
Nguyen, Nhung V
R2D2TB Network, NCT04923958: Rapid Research in Diagnostics Development for TB Network

Recruiting
N/A
10296
RoW
Novel mycobacterial culture techniques, Novel sputum smear microscopy techniques, Sputum-based molecular assays, Tongue swab-based molecular assays, Urine LAM assays, Blood-based host immune response assays, Breath-based assays, Artificial intelligence-based digital health tools, Phage-based assays, Cartridge-based molecular assays for detecting drug resistance, Sequencing-based assays for detecting drug resistance
University of California, San Francisco, University Hospital Heidelberg, Christian Medical College, Vellore, India, Vietnam National Lung Hospital, De La Salle University Medical Center, University of Stellenbosch, Makerere University, Johns Hopkins Bloomberg School of Public Health, Harvard Medical School (HMS and HSDM), Stanford University, Foundation for Innovative New Diagnostics, Switzerland, Socios En Salud Sucursal, Peru, Federal University of Mato Grosso, Medical Research Council, National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia, Centre for Infectious Disease Research in Zambia, National Institute of Allergy and Infectious Diseases (NIAID)
Tuberculosis
05/25
05/25
Gler, Maria Tarcela
BEe-HIVe, NCT04193189: B-Enhancement of HBV Vaccination in Persons Living With HIV (): Evaluation of HEPLISAV-B

Completed
3
640
US, RoW
HEPLISAV-B, ENGERIX-B
National Institute of Allergy and Infectious Diseases (NIAID), Dynavax Technologies Corporation
HIV Infection, Hepatitis B
08/24
08/24
PRISM-TB, NCT06441006: Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Not yet recruiting
2/3
400
RoW
Bedaquiline, Sirturo, Linezolid, Zyvox, Pretomanid, Pretamyl, Moxifloxacin, Avelox, Control Arm FQ-S MDR/RR-TB regimen, designed according to latest international guidelines
University of California, San Francisco, Johns Hopkins University
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR
08/31
08/31
RAD-TB, NCT06192160: Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Suspended
2
315
RoW
Isoniazid, INH, Rifampicin, RIF, Pyrazinamide, PZA, Ethambutol, EMB, Bedaquiline, BDQ, Pretomanid, Pa, Linezolid, LZD, TBI-223, Sutezolid, SZD
National Institute of Allergy and Infectious Diseases (NIAID), TB Alliance
Pulmonary Tuberculosis
03/26
03/27
DRAMATIC, NCT03828201: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Recruiting
2
220
RoW
Delamanid, Deltyba, Levofloxacin, Levaquin, Bedaquiline, Sirturo, Clofazimine, Lamprene, Linezolid, Zyvox
Boston University, Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines
Tuberculosis, Multidrug-Resistant
05/27
05/27
NCT06705478: Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Not yet recruiting
2
186
US, RoW
Pramipexole ER, Escitalopram
National Institute of Allergy and Infectious Diseases (NIAID), Cipla Ltd.
Major Depressive Disorder, Mild Neurocognitive Disorder, HIV
12/26
12/26
GET IT RIgHT, NCT06005610: Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy

Active, not recruiting
2
93
US, RoW
Estradiol
National Institute of Allergy and Infectious Diseases (NIAID)
HIV I Infection
05/27
05/27
Nhung, Viet
DRAMATIC, NCT03828201: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Recruiting
2
220
RoW
Delamanid, Deltyba, Levofloxacin, Levaquin, Bedaquiline, Sirturo, Clofazimine, Lamprene, Linezolid, Zyvox
Boston University, Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines
Tuberculosis, Multidrug-Resistant
05/27
05/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Frias, Melchor V
COMET-PACE, NCT05124210 / 2021-003717-18: Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Terminated
2
8
US
Sotrovimab
GlaxoSmithKline, Vir Biotechnology, Inc.
COVID-19
06/23
06/23
DRAMATIC, NCT03828201: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Recruiting
2
220
RoW
Delamanid, Deltyba, Levofloxacin, Levaquin, Bedaquiline, Sirturo, Clofazimine, Lamprene, Linezolid, Zyvox
Boston University, Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines
Tuberculosis, Multidrug-Resistant
05/27
05/27
NCT05477186: Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Completed
1
185
US, RoW
CV0501 (3 μg), CV0501 (6 μg), CV0501 (12 μg), CV0501 (25 μg), CV0501 (50 μg), CV0501 (100 μg), CV0501 (200 μg)
GlaxoSmithKline
COVID-19, SARS-CoV-2
08/23
08/23
Nguyen, Nhung V
R2D2TB Network, NCT04923958: Rapid Research in Diagnostics Development for TB Network

Recruiting
N/A
10296
RoW
Novel mycobacterial culture techniques, Novel sputum smear microscopy techniques, Sputum-based molecular assays, Tongue swab-based molecular assays, Urine LAM assays, Blood-based host immune response assays, Breath-based assays, Artificial intelligence-based digital health tools, Phage-based assays, Cartridge-based molecular assays for detecting drug resistance, Sequencing-based assays for detecting drug resistance
University of California, San Francisco, University Hospital Heidelberg, Christian Medical College, Vellore, India, Vietnam National Lung Hospital, De La Salle University Medical Center, University of Stellenbosch, Makerere University, Johns Hopkins Bloomberg School of Public Health, Harvard Medical School (HMS and HSDM), Stanford University, Foundation for Innovative New Diagnostics, Switzerland, Socios En Salud Sucursal, Peru, Federal University of Mato Grosso, Medical Research Council, National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia, Centre for Infectious Disease Research in Zambia, National Institute of Allergy and Infectious Diseases (NIAID)
Tuberculosis
05/25
05/25
Gler, Maria Tarcela
BEe-HIVe, NCT04193189: B-Enhancement of HBV Vaccination in Persons Living With HIV (): Evaluation of HEPLISAV-B

Completed
3
640
US, RoW
HEPLISAV-B, ENGERIX-B
National Institute of Allergy and Infectious Diseases (NIAID), Dynavax Technologies Corporation
HIV Infection, Hepatitis B
08/24
08/24
PRISM-TB, NCT06441006: Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Not yet recruiting
2/3
400
RoW
Bedaquiline, Sirturo, Linezolid, Zyvox, Pretomanid, Pretamyl, Moxifloxacin, Avelox, Control Arm FQ-S MDR/RR-TB regimen, designed according to latest international guidelines
University of California, San Francisco, Johns Hopkins University
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR
08/31
08/31
RAD-TB, NCT06192160: Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Suspended
2
315
RoW
Isoniazid, INH, Rifampicin, RIF, Pyrazinamide, PZA, Ethambutol, EMB, Bedaquiline, BDQ, Pretomanid, Pa, Linezolid, LZD, TBI-223, Sutezolid, SZD
National Institute of Allergy and Infectious Diseases (NIAID), TB Alliance
Pulmonary Tuberculosis
03/26
03/27
DRAMATIC, NCT03828201: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Recruiting
2
220
RoW
Delamanid, Deltyba, Levofloxacin, Levaquin, Bedaquiline, Sirturo, Clofazimine, Lamprene, Linezolid, Zyvox
Boston University, Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines
Tuberculosis, Multidrug-Resistant
05/27
05/27
NCT06705478: Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Not yet recruiting
2
186
US, RoW
Pramipexole ER, Escitalopram
National Institute of Allergy and Infectious Diseases (NIAID), Cipla Ltd.
Major Depressive Disorder, Mild Neurocognitive Disorder, HIV
12/26
12/26
GET IT RIgHT, NCT06005610: Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy

Active, not recruiting
2
93
US, RoW
Estradiol
National Institute of Allergy and Infectious Diseases (NIAID)
HIV I Infection
05/27
05/27
Nhung, Viet
DRAMATIC, NCT03828201: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Recruiting
2
220
RoW
Delamanid, Deltyba, Levofloxacin, Levaquin, Bedaquiline, Sirturo, Clofazimine, Lamprene, Linezolid, Zyvox
Boston University, Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines
Tuberculosis, Multidrug-Resistant
05/27
05/27

Download Options